Therapeutic antiviral peptides

Details for Australian Patent Application No. 2009303483 (hide)

Owner InterMune, Inc.

Inventors Seiwert, Scott; Beigelman, Leonid; Buckman, Brad; Serebryany, Vladimir; Stoycheva, Antitsa Dimitrova

Agent Davies Collison Cave

Pub. Number AU-A-2009303483

PCT Pub. Number WO2010/045266

Priority 61/105,746 15.10.08 US; 61/236,741 25.08.09 US

Filing date 13 October 2009

Wipo publication date 22 April 2010

International Classifications

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 209/44 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 235/26 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 277/66 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/68 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/045266 Priority application(s): WO2010/045266

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009303499-Methods for the selection of therapeutic treatments for cancer

2009303475-Spirocyclic GPR40 modulators